Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlobeImmune Inc (NASDAQ:GBIM)

1.14
Delayed Data
As of May 27
 -0.02 / -1.72%
Today’s Change
0.72
Today|||52-Week Range
6.30
-70.54%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close1.16
Today’s open1.12
Day’s range1.12 - 1.20
Volume26,638
Average volume (3 months)150,460
Market cap$6.6M
Dividend yield--
Data as of 05/27/2016

Growth & Valuation

Earnings growth (last year)+94.03%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+8.24%
P/E ratioNM
Price/Sales3.45
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
GALTUGalectin Therapeutic...0.000.00%
GBSNGreat Basin Scientif...+0.02+1.00%
APPYVenaxis Inc-0.06-1.74%
APHBAmpliPhi Biosciences...-0.01-0.44%
Data as of 05/27/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.5M
Annual profit (last year)-$2.8M
Net profit margin-42.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts

Partner Offers

Search for Jobs